Variability in acceptance of organ offers by pediatric transplant centers and its impact on wait‐list mortality

Ellen Mitchell, Kathleen M. Loomes, Robert H. Squires, David Goldberg – 5 March 2018 – Recent data have suggested that pediatric patients wait‐listed for a liver transplantation frequently have liver offers declined. However, factors associated with liver offer decisions and center‐level variability in practice patterns have not been explored.

Dual role for inositol‐requiring enzyme 1α in promoting the development of hepatocellular carcinoma during diet‐induced obesity in mice

Ying Wu, Bo Shan, Jianli Dai, Zhixiong Xia, Jie Cai, Tianwei Chen, Songya Lv, Yuxiong Feng, Ling Zheng, Yan Wang, Jianfeng Liu, Jing Fang, Dong Xie, Liangyou Rui, Jianmiao Liu, Yong Liu – 5 March 2018 – Obesity is associated with both endoplasmic reticulum (ER) stress and chronic metabolic inflammation. ER stress activates the unfolded protein response (UPR) and has been implicated in a variety of cancers, including hepatocellular carcinoma (HCC). It is unclear whether individual UPR pathways are mechanistically linked to HCC development, however.

Alterations in gut microbial function following liver transplant

Jasmohan S. Bajaj, Genta Kakiyama, I. Jane Cox, Hiroshi Nittono, Hajime Takei, Melanie White, Andrew Fagan, Edith A. Gavis, Douglas M. Heuman, Ho Chong Gilles, Phillip Hylemon, Simon D. Taylor‐Robinson, Cristina Legido‐Quigley, Min Kim, Jin Xu, Roger Williams, Masoumeh Sikaroodi, William M. Pandak, Patrick M. Gillevet – 3 March 2018 – Liver transplantation (LT) improves daily function and ameliorates gut microbial composition. However, the effect of LT on microbial functionality, which can be related to overall patient benefit, is unclear and could affect the post‐LT course.

Crosstalk between mesenchymal stem cells and T regulatory cells is crucially important for the attenuation of acute liver injury

Marina Gazdic, Bojana Simovic Markovic, Aleksandar Arsenijevic, Nemanja Jovicic, Aleksandar Acovic, C. Randall Harrell, Crissy Fellabaum, Valentin Djonov, Nebojsa Arsenijevic, Miodrag L. Lukic, Vladislav Volarevic – 3 March 2018 – One of the therapeutic options for the treatment of fulminant hepatitis is repopulation of intrahepatic regulatory cells because their pool is significantly reduced during acute liver failure.

Subscribe to